A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors

NCT03330106 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Neoplasm

Interventions

DRUG: Pevonedistat
DRUG: Docetaxel
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Millennium Pharmaceuticals, Inc.